Literature DB >> 11280229

Prevalence of hypertension amongst Mumbai executives.

M P Anand1.   

Abstract

OBJECTIVE: To find out prevalence of hypertension amongst Mumbai executives.
METHODS: Data of annual medical check-up of 1653 executives was evaluated. Blood pressure was measured as per JNC VI/WHO guidelines.
RESULTS: Overall prevalence of hypertension amongst Mumbai executives was 26.86%. 21.28% of executives who were hypertensive based on causal reading were later found to have normal or high normal blood pressure.
CONCLUSION: For all epidemiological surveys, blood pressure must be recorded on at least two subsequent occasions after initial screening.

Entities:  

Mesh:

Year:  2000        PMID: 11280229

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

Review 1.  Convergence in urban-rural prevalence of hypertension in India.

Authors:  R Gupta
Journal:  J Hum Hypertens       Date:  2015-06-25       Impact factor: 3.012

2.  Prevalence, awareness, and control of hypertension in the slums of Kolkata.

Authors:  Suvro Banerjee; Tapan Kumar Mukherjee; Srabashi Basu
Journal:  Indian Heart J       Date:  2016-01-11

3.  Prevalence of hypertension and prehypertension in a community-based primary health care program villages at central India.

Authors:  Ramaswamy Premkumar; John Pothen; Jeeva Rima; Shobha Arole
Journal:  Indian Heart J       Date:  2016-01-13

4.  Risk of high blood pressure in salt workers working near salt milling plants: a cross-sectional and interventional study.

Authors:  Kripa Ram Haldiya; Murli Lal Mathur; Raman Sachdev; Habibulla N Saiyed
Journal:  Environ Health       Date:  2005-07-25       Impact factor: 5.984

5.  Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study.

Authors:  Ajay K Singh; Youssef M K Farag; Bharati V Mittal; Kuyilan Karai Subramanian; Sai Ram Keithi Reddy; Vidya N Acharya; Alan F Almeida; Anil Channakeshavamurthy; H Sudarshan Ballal; Gaccione P; Rajan Issacs; Sanjiv Jasuja; Ashok L Kirpalani; Vijay Kher; Gopesh K Modi; Georgy Nainan; Jai Prakash; Devinder Singh Rana; Rajanna Sreedhara; Dilip Kumar Sinha; Shah Bharat V; Sham Sunder; Raj K Sharma; Sridevi Seetharam; Tatapudi Ravi Raju; Mohan M Rajapurkar
Journal:  BMC Nephrol       Date:  2013-05-28       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.